EUROGIN2011
HPV Associated Diseases and Cancer-From Reality now to the Future
May 08, 2011 - May 11, 2011 | Congress Center Lisbon, Portugal
The meeting aimed at developing a full review of current scientific developments in the field of cervical cancer control and beyond, including vulvar, anal and head & neck HPV associated diseases. The event highlight recent advances, and provided a forum for exchanging information on early detection, new diagnostic and therapeutic procedures and prevention strategies including screening and HPV vaccination.
The purpose of the conference was not only to highlight new developments, but also to widen the discussion beyond the purely medical aspects and to address public education issues.
Presentations
Natural history revisited: age specific relationship and implications for clinical practice
Basic research and fundamentals: state of the art
Vulvar HPV related lesions: current knowledge
HPV related neoplasia and cancer in anus, external genitalia and head & neck – facts and figures
Anal neoplasia: epidemiology, diagnostics and prevention
HPV related neoplasia and cancer in anus, external genitalia and head & neck – facts and figures
Penile HPV associated diseases: what the clinician should know
HPV related neoplasia and cancer in anus, external genitalia and head & neck – facts and figures
Head and neck cancer: the significance of HPV infection and treatment issues
HPV related neoplasia and cancer in anus, external genitalia and head & neck – facts and figures
Optimal screening intervals
Cervical cancer screening – role of molecular testing
Current knowledge on screening of women less than 30
Cervical cancer screening – role of molecular testing
Management of cytonegative / HPV positive women
Cervical cancer screening – role of molecular testing
Exiting women from screening
Cervical cancer screening – role of molecular testing
Cervical cancer screening as a post-vaccination surveillance activity
Cervical cancer screening – role of molecular testing
Vaccine benefits following sexual debut (catch- up/adult)
HPV vaccination – current knowledge and the road to the future
New evidence for vaccination of males
HPV vaccination: Current knowledge and the road to the future
An evaluation of the long-term effectiveness, immunogenicity and safety of the quadrivalent vaccine in previously vaccinated women
HPV vaccination: Current knowledge and the road to the future
The burden of HPV associated penile cancer
Penile HPV related diseases revisited
Male sexual behaviour – a risk factor for cervical cancer?
Penile HPV related diseases revisited
The global spectrum of HPV related diseases in males
Penile HPV related diseases revisited
Management of penile HPV associated lesions
Penile HPV related diseases revisited
HPV vaccination: what have we learned from the clinical trials?
Penile HPV related diseases revisited
Impact of male circumcision on women with HPV genital disease
Penile HPV related diseases revisited
The burden of the diseases and natural history
Anal HPV associated diseases and cancer: State of the art
Factors influencing HPV dysplasia and anal cancer following HPV infection
Anal HPV associated diseases and cancer: State of the art
Diagnostic methods and clinical features
Anal HPV associated diseases and cancer: State of the art
Who should be screened? Is screening an effective tool?
Anal HPV associated diseases and cancer: State of the art
Current management of AIN3 and cancer
Anal HPV associated diseases and cancer: State of the art
Assessing inequalities over the world (access, resources, education) and potential solutions
Can we target the adult population at high risk of cervical cancer? Consequences on screening, management and vaccination
Epidemiologic, genetic, behavioural factors and the male partner influence: are they important?
Can we target the adult population at high risk of cervical cancer? Consequences on screening, management and vaccination
Significance of molecular testing/markers and age of exposure to HPV
Can we target the adult population at high risk of cervical cancer? Consequences on screening, management and vaccination
Integrating and implementing screening and vaccination programs for high risk populations
Can we target the adult population at high risk of cervical cancer? Consequences on screening, management and vaccination
Molecular diagnostic methods and prognostic markers utility
Head and neck HPV associated cancer: State of the art
Tumor HPV status management and survival
Head and neck HPV associated cancer: State of the art
The potential impact of HPV vaccines
Head and neck HPV associated cancer: State of the art
The burden of HPV related head and neck cancer
HPV and heterogeneity of head and neck cancers
Comparison of molecular methods for detection of HPV in oral and oropharyngal squamous carcinoma
HPV and heterogeneity of head and neck cancers
Infos
| Date | May 08, 2011 - May 11, 2011 |
|---|---|
| Program-Link: | http://www.eurogin.com/2011/finalprogram.pdf |
| Website: | http://www.eurogin.com/2011/ |
| Location: | Congress Center Lisbon, Portugal ; |
| Category: | Medicine; |